SPECT在抑郁症研究中的应用

于璟; 唐一源

SPECT在抑郁症研究中的应用

于璟 , 唐一源

文章导航 > 国际放射医学核医学杂志 > 2007, 31 > 1: (13-16)

引用本文:

Citation:

SPECT在抑郁症研究中的应用

于璟^1,2, ,,
唐一源¹

1. 116027 大连, 大连理工大学神经信息研究所;
2. 116027 大连, 大连医科大学第二附属医院核医学科

通讯作者: 于璟, tjkd1605@sohu.com ;

中图分类号: R817.4

The use of SPECT in the study of depression

YU Jing^1,2, ,,
TANG Yi-yuan¹

1. Institute of Neuroinformatics, Dalian University of Technology, Dalian 116027, Chino;
2. Department of Nuclear Medicine, the Second Affiliated Hospital of Dalian Medical University, Dalian 116027, China

Corresponding author: YU Jing, tjkd1605@sohu.com ;

CLC number: R817.4

摘要: 功能显像是研究情感性精神障碍的有效手段。在抑郁症研究中常用的SPECT方法有灌注显像、代谢显像和受体显像,分别反映脑组织的血流、代谢情况及受体的分布和功能。数据处理方法有感兴趣区法和统计参数图法。主要综述各种显像和数据处理方法的特性、抑郁症患者SPECT脑显像的表现、血流异常的脑区及受体显像的发现,探讨SPECT在抑郁症发病机制研究中的应用,分析当前研究中存在的问题并对未来的研究进行展望。
- 抑郁症 /
- 体层摄影术,发射型计算机,单光子 /
- 情绪障碍
Abstract: Functional imaging is an effective methods in the study of psychological disturbances. The SPECT imaging methods commonly used in the study of depression are cerebral blood flow imaging, cerebral metabolic imaging and neuroreceptor imaging, which reflect the cerebral blood perfusion, cerebral metabolism, and the distribution and function of neuroreceptors respectively. The techniques in data processing include and statistical parametric mapping. This review summarizes the feature of the imaging and data processing methods, the manifestation of SPECT images in depressive patients, the brain region with abnormal blood flow and the findings in neuroreceptor imaging, analyzes the problems in current reports and prospects future studies.
- Depression /
- Tomography, emission-computed, single photon /
- Psychological disturbance
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	韩济生.神经科学原理(第二版).北京:北京医科大学出版社,1999.1137.
[2]	Bonne O, Louzoun Y, Aharon I, et al. Cerebral blood flow in depressed Patients:a methodological comparison of statistical parametric mapping and region of interest analyses. Psychiatry Res, 2003, 122(1):49-57.
[3]	Smith DJ, Cavanagh JT. The use of single photon emission computed tomography in depressive disorders. Nucl Med Commun,2005, 26(3):197-203.
[4]	Ohgami H, Nagayama H, Akiyoshi J, et al. Contributing factors to changes of cerebral blood flow in major depressive Disorder. J Affect Disord, 2005, 87(1):57-63.
[5]	Benabarre A,Vieta E, Martin F, et al. Clinical value of ^99mTc-HMPAO SPECT in depressed bipolar Ⅰ patients. Psychiatry Res,2004, 132(3):285-289.
[6]	Skaf CR, Yamada A, Garrido GE. Psychotic symptoms in major depressive disorder are associated with reduced regional cerebral blood flow in the subgenual anterior cingulated cortex:a voxelbased single photon emission computed tomography (SPECT)study. J Affect Disord, 2002, 68(2-3):295-305.
[7]	Cho MJ, Lyoo IK, Lee DW, et al. Brain single photon emission computed tomography findings in depressive pseudodementia patients. J Affect Disord, 2002, 69(1-3):159-166.
[8]	Gonul AS, Kula M, Bilgin AG, et al. The regional cerebral blood flow changes in major depressive disorder with and without psychotic features. Prog Neuro Psychopharmacol Biol Psychiatry, 2004,28(6):1015-1021.
[9]	American Psychiatric Association. Diagnostic and dtatistical manual of mental disorders. 4th edition, Washington DC:American Psychiatric Association, 1994.
[10]	Bonne O, Krausz Y, Gorfine M, et al. Cerebral hypoperfusion inmedication resistant depressed patients assessed by Tc-99m HMPAO SPECT. J Affect Disord, 1996, 41(3):163-171.
[11]	Drevets WC, Gadde K, Krishnan R. Neuroimaging studies of depression. In:Charney DS, Netsler EJ,Bunney BJ, (editors):Neurobiology of Mental Illness. New York:Oxford Press, 1999.394-418.
[12]	Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry, 2000, 48(8):813-829.
[13]	Perico CA, Skaf CR, Yamada A, et al. Relationship between regional cerebral blood flow and separate symptom clusters of major depression:a single photon emission computed tomographystudy using statistical parametric mapping. Neurosci Lett,2005, 384(3):265-270.
[14]	Navano V, Gasto C, Lomena F, et al. Frontal cerebral perfusion after antidepressant drug treatment versus ECT in elderly patients with major depression:A 12-month follow-up control study. J Clin Psychiatry, 2004, 65(5):656-661.
[15]	Davies J, Lloyd KR, Jones IK, et al. Changes in regional cerebral blood flow with venlafaxine in the treatment of major depression.Am J Psychiatry, 2003,160(2):374-376.
[16]	Mottaghy FM, Keller CE, Gangitano M, et al. Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients. Psychiatry Res, 2002, 115(1-2):1-14.
[17]	Navarro V, Gasto C, Lomena F, et al. Normalization of frontal cerebral perfusion in remitted elderly major depression:12-month follow-up study. Neuroimaging, 2002, 16(3-p1):781-787.
[18]	Klimke A, Larisch R, Janz A, et al. Dopamine D2 receptor binding before and after treatment of major depression measured by [¹²³I]IBZM SPECT. Psychiatry Res, 1999, 90(2):91-101.
[19]	Brunswick DJ, Amsterdam JD, Mozley PD, et al. Greater availablity of brain dopamine transporters in major depression shown by ^99mTc-TRODAT-1 SPECT imaging. Am J Psychiatry, 2003, 160(10):1836-1841.
[20]	Malison RT, Price LH, Berman R, et al. Reduced brain serotonin transporter availability in major depression as measured by [¹²³I]-2beta-carbomethoxy-3 beta-(4-iodophenyl) tropane and single photon emission computed tomography. Biol Psychiatry, 1998, 44(11):1090-1098.
[21]	Willeit M, Praschak-Rieder N, Neumeister A, et al.[¹²³I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder.Biol Psychiatry, 2000, 47(6):482-489.
[22]	Staley JK, Sanacora G, Tamagnan G, et al. Sex differences in diencephalons serotonin transporter availability in major depression. Biol Psychiatry, 2006, 59(1):40-47.
[23]	De Win MM, Reneman L, Reitsma JB, et al. Mood disorders and serotonin transporter density in ecstasy users-the influence of long-term abstention, dose, and gender. Psychopharmacology, 2004, 173(3-4):376-382.
[24]	Newberg AB, Amsterdam JD, Wintering N, et al. ¹²³I-ADAM binding to serotonin transporters in patients with major depression and healthy controls:a preliminary study. J Nucl Med, 2005, 46(6):973-977.
[25]	Schins A, Van Kroonenburgh M, Van laere K, et al. Increased cerebral serotonin-2A receptor binding in depressed patients with myocardial infarction. Psychiatry Res, 2005, 139(2):155-163.

[1]	原凌 , 刘建中 , 武志芳 . SPECT脑血流灌注显像和受体显像对抑郁症的研究. 国际放射医学核医学杂志, 2007, 31(5): 277-280.
[2]	冯苏洋 , 邢炯 , 舒敏 , 刘加成 . 抑郁症相关执行功能障碍的磁共振成像研究进展. 国际放射医学核医学杂志, 2021, 45(12): 795-799. doi: 10.3760/cma.j.cn121381-202012010-00117
[3]	邱晶 , 王慧 , 王蕾 , 周治强 , 徐雅洁 , 顾卫国 . 首次发作抑郁症患者静息态fMRI低频振幅的初步研究. 国际放射医学核医学杂志, 2020, 44(8): 499-506. doi: 10.3760/cma.j.cn121381-201904004-00061
[4]	赵晋华 , 林祥通 . 抑郁症的放射性核素脑血流灌注和脑受体显像研究进展. 国际放射医学核医学杂志, 1998, 22(2): 49-51.
[5]	李祖贵 . 轻度认知障碍的功能性神经影像学研究进展. 国际放射医学核医学杂志, 2006, 30(2): 76-79.
[6]	袁建伟 , 冯彦林 , 贺小红 , 余丰文 , 刘德军 , 温广华 , 黄克敏 . ^20lTl定量门控心肌灌注体层显像与^99mTc-红细胞门控心血池显像测定左心室射血分数的对比研究. 国际放射医学核医学杂志, 2008, 32(2): 86-88.
[7]	李崇国 , 吴大可 , 郎锦义 . 基于非均匀有理B样条的四维心脏-躯干体模及其在医学影像研究中的应用. 国际放射医学核医学杂志, 2008, 32(6): 367-371.
[8]	冯菲 , 赵德善 , 耿会霞 , 吴利翔 , 刘建中 , 李思进 . 原发性腹膜砂粒体癌⁹⁹Tc^m-亚甲基二膦酸盐SPECT-CT全身骨显像一例报告. 国际放射医学核医学杂志, 2009, 33(5): 285-286. doi: 10.3760/cnla.j.issn.1673-4114.2009.05.009
[9]	咸雨蔚 , 左书耀 . 甲状腺肿瘤SPECT-CT融合显像的应用近况. 国际放射医学核医学杂志, 2006, 30(3): 157-160.
[10]	张金山 , 吴兆红 , 邓咏梅 , 李敏 , 林炎彬 , 黄桂敏 . ^99mTc-MIBI联合^99mTc-HL91乏氧显像对60例原发性肺癌的诊断评价. 国际放射医学核医学杂志, 2006, 30(5): 287-289.
[11]	薛荣梅 , 宋丽萍 . 门控心肌灌注SPECT在冠心病方面的应用进展. 国际放射医学核医学杂志, 2006, 30(6): 353-355.

点击查看大图

计量

文章访问数: 1511
HTML全文浏览量: 179
PDF下载量: 2

SPECT在抑郁症研究中的应用

于璟^1,2, ,
唐一源¹

通讯作者: 于璟, tjkd1605@sohu.com;

1. 116027 大连, 大连理工大学神经信息研究所;
2. 116027 大连, 大连医科大学第二附属医院核医学科

收稿日期: 2006-05-04

关键词:

摘要: 功能显像是研究情感性精神障碍的有效手段。在抑郁症研究中常用的SPECT方法有灌注显像、代谢显像和受体显像,分别反映脑组织的血流、代谢情况及受体的分布和功能。数据处理方法有感兴趣区法和统计参数图法。主要综述各种显像和数据处理方法的特性、抑郁症患者SPECT脑显像的表现、血流异常的脑区及受体显像的发现,探讨SPECT在抑郁症发病机制研究中的应用,分析当前研究中存在的问题并对未来的研究进行展望。